Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/1996
03/20/1996EP0701439A1 Stable copper(i) complexes and methods related thereto
03/20/1996EP0701434A1 Preparations containing silicon dioxide to improve the taste thereof
03/20/1996EP0656776B1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt
03/20/1996EP0489072B1 Treatment of chronic inflammatory conditions
03/20/1996CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders
03/20/1996CN1118989A Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
03/20/1996CA2158517A1 Aminomethylphosphonic and aminomethylphosponic acid derivates and their use for treating degenerative joint disorders
03/19/1996US5500429 Cardiovascular
03/19/1996US5500417 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents
03/19/1996CA2109800C N-hydroxyurea derivatives which inhibit lipoxygenase
03/17/1996CA2158222A1 Use of substituted cyclopentane- di- and triones
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
03/14/1996WO1996007657A1 Pyrimido[5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them
03/14/1996WO1996007651A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/14/1996WO1996007649A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2198477A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/13/1996EP0700387A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
03/13/1996EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
03/13/1996EP0700301A1 Peptides and compounds that bind to elam-1
03/13/1996EP0690841A4 Synthetic matrix metalloprotease inhibitors and uses thereof
03/13/1996EP0618899B1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
03/13/1996EP0544880B1 Method of preparing diacetyl rhein
03/13/1996EP0489108B1 Use of spiperone derivatives for immunosuppression
03/13/1996CN1031266C Process for preparation of heterocycle ether derivatives
03/12/1996US5498729 Prodrug compositions
03/12/1996US5498405 Indole alkaloids useful as UV protective and anti-inflammatory agents
03/07/1996WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996WO1996006640A1 Bioadhesive-wound healing composition
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006607A1 Indole alkaloids useful as uv protective and anti-inflammatory agents
03/07/1996WO1996006528A1 Ionene polymers containing biologically-active anions
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996CA2194876A1 Bioadhesive-wound healing composition
03/06/1996EP0699679A1 Tetrahydropyranyl compounds, process for their preparation and pharmaceutical compositions containing them
03/06/1996EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists
03/06/1996EP0699444A2 Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat
03/06/1996EP0699436A1 Controlled release formulation
03/06/1996EP0699199A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
03/06/1996EP0699195A1 Thioindole pyperidinyl derivatives used as antalgics
03/06/1996EP0699192A1 Substituted oxazolyl compounds for the treatment of inflammation
03/06/1996EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/06/1996EP0699188A1 Quinoline derivatives as leukotriene antagonists
03/06/1996EP0699180A1 Bicyclic amide derivatives and their use as muscle relaxants
03/06/1996EP0587723B1 Quinuclidine derivatives
03/06/1996EP0395653B1 Synovial phospholipases
03/06/1996CN1118141A Combination of a soluble complement receptor -1(SCR1) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation
03/06/1996CN1117874A Nasally administrable compositions
03/06/1996CN1031193C Polypeptide and method for preparing same
03/05/1996US5496950 Antiinflammatory agents
03/05/1996US5496851 Antiinflammatory, anticoagulants
03/05/1996US5496828 Methods of inhibiting ulcerative mucositis
03/01/1996CA2157156A1 New tetrahydropyranic compounds, process for their preparation and pharmaceutical composition containing them
02/1996
02/29/1996WO1996006169A1 Human chemokine beta-9
02/29/1996WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
02/29/1996WO1996006095A1 Endothelin antagonists
02/29/1996WO1996006094A1 Novel substituted piperidines useful for the treatment of allergic diseases
02/29/1996WO1996006093A1 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
02/29/1996WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
02/29/1996WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists
02/29/1996WO1996006078A1 N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists
02/29/1996WO1996006077A1 N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists
02/29/1996WO1996006074A1 Metalloproteinase inhibitors
02/29/1996WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use
02/29/1996WO1996005856A1 Human chemokine polypeptides
02/29/1996WO1996005838A2 Combined preparation for the therapy of immune diseases
02/29/1996WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine
02/29/1996WO1996005831A1 Methods of inhibiting ulcerative mucositis
02/29/1996DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other
02/29/1996DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects
02/29/1996CA2517691A1 Endothelin antagonists
02/29/1996CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells
02/29/1996CA2198206A1 Human chemokine beta-9
02/29/1996CA2198016A1 Methods of inhibiting ulcerative mucositis
02/29/1996CA2196979A1 7-azabicyclo¬2.2.1|-heptane and -heptene derivatives as cholinergic receptor ligands
02/28/1996EP0698594A1 Pharmaceutical anthraquinone derivatives
02/28/1996EP0698031A1 SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
02/28/1996EP0697880A1 Inhibition of leukocyte adhesion
02/28/1996EP0697873A1 Olefin-substituted long chain compounds
02/28/1996EP0697868A1 Methods and compositions using optically pure (+)-zileuton
02/28/1996EP0697864A1 Treatment of septic shock
02/28/1996EP0588897B1 Non-chlorofluorocarbon aerosol formulations
02/28/1996EP0547224B1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT
02/28/1996CN1117484A Fatty acid derivatives
02/28/1996CN1031132C Process for preparation of carbocyclic adenosine analogs useful as immunosuppressants
02/27/1996US5494927 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
02/27/1996CA2155447A1 Substituted biphenyl isoxazole sulfonamides
02/27/1996CA2046970C Anti-inflammatory composite
02/27/1996CA2030204C Pharmaceutical compositions of tebufelone
02/27/1996CA1338083C Ozonides of terpenes and their medical uses
02/25/1996CA2156700A1 Pharmaceutical compounds
02/24/1996CA2156768A1 Pharmaceutical formulations, their preparation and use
02/22/1996WO1996005221A1 Calcitonin receptor